| This article has been cited by |
| 1 | The effect of statin therapy on disease-related outcomes in idiopathic pulmonary fibrosis: A systematic review and meta-analysis | |
| J.W. Kim,K. Barrett,Y. Loke,A.M. Wilson |
| Respiratory Medicine and Research.2021;80()100792 |
| [DOI] |
|
| 2 | Stage-specific therapy for hypertrophic cardiomyopathy | |
| Alessia Argirò,Mattia Zampieri,Alberto Marchi,Francesco Cappelli,Annamaria Del Franco,Carlotta Mazzoni,Franco Cecchi,Iacopo Olivotto |
| European Heart Journal Supplements.2023;25(Supplement_C)C155 |
| [DOI] |
|
| 3 | Pharmacological Management of Hypertrophic Cardiomyopathy: From Bench to Bedside | |
| Chiara Palandri,Lorenzo Santini,Alessia Argirò,Francesca Margara,Ruben Doste,Alfonso Bueno-Orovio,Iacopo Olivotto,Raffaele Coppini |
| Drugs.2022;82(8)889 |
| [DOI] |
|
| 4 | Current State of Hypertrophic Cardiomyopathy Clinical Trials | |
| Hussein H. Khachfe,Hamza A. Salhab,Mohamad Y. Fares,Hassan M. Khachfe |
| Global Heart.2019;14(3)317 |
| [DOI] |
|
| 5 | Hypertrophic cardiomyopathy: an up-to-date snapshot of the clinical drug development pipeline | |
| Juan Tamargo,María Tamargo,Ricardo Caballero |
| Expert Opinion on Investigational Drugs.2022;31(10)1027 |
| [DOI] |
|
| 6 | Novel Pharmacotherapy for Hypertrophic Cardiomyopathy | |
| Timothy C. Wong,Matthew Martinez |
| Cardiology Clinics.2019;37(1)113 |
| [DOI] |
|
| 7 | Transgenic rabbit models for cardiac disease research | |
| Tibor Hornyik,Marina Rieder,Alessandro Castiglione,Peter Major,Istvan Baczko,Michael Brunner,Gideon Koren,Katja E. Odening |
| British Journal of Pharmacology.2022;179(5)938 |
| [DOI] |
|
| 8 | New perspectives in the pharmacological treatment of hypertrophic cardiomyopathy | |
| Sérgio Maltês,Luis Rocha Lopes |
| Revista Portuguesa de Cardiologia (English Edition).2020;39(2)99 |
| [DOI] |
|
| 9 | Novel Pharmacotherapy in Hypertrophic Cardiomyopathy | |
| Gabriela Andries,Srikanth Yandrapalli,Srihari S. Naidu,Julio A. Panza |
| Cardiology in Review.2018;26(5)239 |
| [DOI] |
|
